GlassScriptPhysician profile
Kim D Vernon
NPI 1952394652
$1,348.09
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $515 · 2020: $293 · 2021: $254 · 2022: $227 · 2023: $23.82 · 2024: $35.13.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $58.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $58.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $184.30 | 2019-2022 | |
| Exeltis, USA INC. | $162.15 | 2019-2022 | |
| Amgen INC. | $104.19 | 2019-2024 | Prolia, Evenity |
| Pfizer INC. | $90.50 | 2019-2021 | |
| Hologic Sales and Service, LLC | $89.55 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $72.93 | 2019-2020 | |
| Smith+Nephew, INC. | $66.92 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $65.39 | 2019 | |
| Therapeuticsmd, INC. | $62.31 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $48.88 | 2021-2022 | |
| Avion Pharmaceuticals | $40.68 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $33.96 | 2019 | |
| Millicent US INC | $32.73 | 2020 | |
| Radius Health, INC. | $31.44 | 2019 | |
| Cook Medical LLC | $26.56 | 2019-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $25.02 | 2019-2020 | |
| Minerva Surgical, INC | $24.19 | 2022 | |
| Evofem Biosciences, INC. | $23.86 | 2021 | |
| Innovation Technologies INC | $23.82 | 2023 | Irrisept |
| Agile Therapeutics, INC. | $20.33 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.76 | 2020 | |
| Myovant Sciences INC. | $16.48 | 2021 | |
| Sage Therapeutics, LLC | $12.93 | 2022 | |
| Dysis Medical, INC. | $12.77 | 2022 | |
| Mylan Pharmaceuticals INC. | $12.59 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.02 | 2020 | |
| Coloplast Corp | $11.98 | 2019 | |
| Astellas Pharma US INC | $11.77 | 2021 | |
| Ferring Pharmaceuticals INC. | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kim Vernon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.